Citations

Showing 10 of 108119 citations.

Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).
Kim, George P., Lenz, Heinz‐Josef , Verma, Udit, Saltzman, Marc, Fuloria, Jyotsna, Khojasteh, Ali , Wiesenfeld, Martin, Cihon, Frank, Wagner, Andrea, Grothey, Axel, Cutsem, Eric Van , Wagner, Andrea

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14649-e14649

10.1200/jco.2015.33.15_suppl.e14649 Get It

Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.
Gangadhar, Tara C., Hamid, Omid , Dummer, Reinhard , Mehnert, Janice M. , Celentano, Kellie Ann, Lindia, Jill A., Chatterjee, Manash , Turner, David C. , Mayawala, Kapil , Elassaiss‐Schaap, Jeroen , Alwis, Dinesh P. de, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Kefford, Richard , Joseph, Richard W. , Puzanov, Igor , Robert, Caroline , Ribas, Antoni , Daud, Adil

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3068-3068

10.1200/jco.2015.33.15_suppl.3068 Get It

Atypical patterns of response in patients (pts) with metastatic melanoma treated with pembrolizumab (MK-3475) in KEYNOTE-001.
Hamid, Omid , Kefford, Richard , Hwu, Wen‐Jen , Gangadhar, Tara C., Dronca, Roxana , Patnaik, Amita , Zarour, Hassane M. , Li, Xiaoyun , Xue, Dahai, Ebbinghaus, Scot, Kang, Soonmo Peter, Perrone, Andrea , Hodi, F. Stephen , Wolchok, Jedd D. , Ribas, Antoni , Robert, Caroline , Weber, Jeffrey S. , Joshua, Anthony M. , Daud, Adil , Joseph, Richard W. , Perrone, Andrea Marie

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3000-3000

10.1200/jco.2015.33.15_suppl.3000 Get It

Phase I dose-escalation study with extended daily administration of Debio1143, an oral inhibitor of apoptosis protein inhibitor, in patients with solid tumors.
Pitot, Henry C., Hurwitz, Herbert I. , Zanna, Claudio , Brill, Jeffrey Mark, Vuagniaux, Grégoire, Rouits, Elisabeth , Sorensen, John M., Smith, David C.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2531-2531

10.1200/jco.2015.33.15_suppl.2531 Get It

First-in-human, phase I study assessing imalumab (Bax69), a first-in-class anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody in advanced solid tumors.
Patel, Manish R. , Sachdev, Jasgit C. , Hart, Lowell L., Halama, Neils, Ramanathan, Ramesh K., Sarantopoulos, John , Yazji, Salim, Jaeger, Dirk, Adib, Deyaa, Kerschbaumer, Randolf J. , Mahalingam, Devalingam , Liu, Xiaochun , Tsimberidou, Apostolia M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2518-2518

10.1200/jco.2015.33.15_suppl.2518 Get It

Effects of pazopanib therapy on mean corpuscular volume in patients enrolled in MC1112: Analysis of correlation with time to disease progression in solid tumors.
Burton, Jill K., Qin, Rui , Erlichman, Charles , Harris, Pamela Jo , Bible, Keith C. , Kumar, Aditi , Suman, Vera J. , Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e13596-e13596

10.1200/jco.2015.33.15_suppl.e13596 Get It

A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
Hendrickson, Andrea E. Wahner , Menefee, Michael E., Hartmann, Lynn C., Long, Harry J., Northfelt, Donald W. , Boakye-Agyeman, Fleix, Flatten, Karen S., Lensing, Janet L., Erlichman, Charles , Reid, Joel M. , Poirier, Guy G. , Kaufmann, Scott H. , Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS2618-TPS2618

10.1200/jco.2015.33.15_suppl.tps2618 Get It

Randomized, placebo-controlled, phase II study of dasatinib with standard chemo-radiotherapy for newly diagnosed glioblastoma (GBM), NCCTG N0877 (Alliance).
Anderson, S. Keith , Leinweber, Clinton, Buckner, Jan C. , Geoffroy, Francois J., Lesser, Glenn J. , Jaeckle, Kurt A. , Laack, Nadia N. , Galanis, Evanthia , Giannini, Caterina , Johnson, Derek R. , Sarkaria, Jann N.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2013-2013

10.1200/jco.2015.33.15_suppl.2013 Get It

What do young adults with cancer indicate as their primary need for financial grant support?
Leach, Celeste Bunny, Jaeckle, Kurt A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e12658-e12658

10.1200/jco.2015.33.15_suppl.e12658 Get It

Clinical utility of expanded screening of the KRAS and NRAS genes for Metastatic Colorectal Cancer: Evaluation of the CRC RAScan tumor test as a companion diagnostic to determine efficacy of anti-EGFR therapies.
Peterson, Stephanie, Bevilacqua, Jen, Veys, Stephanie, Rosendale, Vicki, Legendre, B. L. , Bible, Keith C. , Richardson, Katherine Anne, Peterson, Stephanie, Legendre, Benjamin L., Reddi, Honey V.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e12554-e12554

10.1200/jco.2015.33.15_suppl.e12554 Get It